Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008128

EVP, Chief Dev. Officer sold 1,991 shares at $9.86 ($19,635)

From the SEC's structured data for this filing

Trades in this filing

Frenkel Ran · EVP, Chief Dev. Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-07 Sale : show line 1 in the form −1,991 $9.86 $19,635 104,632 D
Open-market sales · 1,991 sh · avg $9.86 · $19,635
Loading xslF345X03/doc4.xml…